- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 12.8M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 12.82M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 12.82M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $0 |
| Capex | Q1 2026 · Mar 31, 2025 | $8.51K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $228.03K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $330.73K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $2.4M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $2.17M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $13.27M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $13.07M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $11.98M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $11.69M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $496.53K |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $388.6K |
| Current Assets | Q1 2026 · Mar 31, 2026 | $13.69M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $13.39M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $13.77M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $13.46M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.02 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.02 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $180.79K |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $187.51K |
| Net Income | Q1 2026 · Mar 31, 2026 | $193.67K |
| Net Income | Q1 2026 · Mar 31, 2025 | $292.66K |
| Operating Income | Q1 2026 · Mar 31, 2026 | $172.68K |
| Operating Income | Q1 2026 · Mar 31, 2025 | $314.42K |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.5M |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.82M |